Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Second Amended and Restated Certificate of Incorporation
- 3.2 By-laws
- 10.1 Shared Services Agreement
- 10.2 Trademark & Trade Name License Agreement
- 10.3 Trademark & Trade Name Sublicense Agreement
- 10.4 Proprietary Software License Agreement
- 16.1 Letter from Grant Thornton LLP to the Sec
- 23.1 Consent of Pricewaterhousecoopers LLP
MDRX similar filings
- 27 Oct 08 Regulation FD Disclosure
- 23 Oct 08 Departure of Directors or Principal Officers
- 23 Oct 08 Allscripts Reports Preliminary Third Quarter 2008 Results
- 17 Oct 08 Entry into a Material Definitive Agreement
- 10 Oct 08 Nasdaq Informs Allscripts of Change in Anticipated Date on which Allscripts Common Stock will Trade Without the Right to the Special Cash Dividend
- 6 Oct 08 Allscripts Stockholders Approve Misys Transaction Proposals
- 2 Oct 08 Other Events
Filing view
External links
Exhibit 16.1
October 17, 2008
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Allscripts-Misys Healthcare Solutions, Inc.
File No. 0-32085
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Allscripts-Misys Healthcare Solutions, Inc. dated October 17, 2008, and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ Grant Thornton LLP
Chicago, Illinois
October 17, 2008